These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 19022326)

  • 41. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action.
    Cruzan G; Bus J; Banton M; Gingell R; Carlson G
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):205-18. PubMed ID: 19589367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Budlein A from Viguiera robusta inhibits leukocyte-endothelial cell interactions, adhesion molecule expression and inflammatory mediators release.
    Nicolete R; Arakawa NS; Rius C; Nomizo A; Jose PJ; Da Costa FB; Sanz MJ; Faccioli LH
    Phytomedicine; 2009 Oct; 16(10):904-15. PubMed ID: 19524419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the antitumoral effect of dihydrocucurbitacin-B in both in vitro and in vivo models.
    Siqueira JM; Gazola AC; Farias MR; Volkov L; Rivard N; de Brum-Fernandes AJ; Ribeiro-do-Valle RM
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):529-38. PubMed ID: 19184021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of a novel battery of bioassays for the biological characterisation of hazardous wastes.
    Pablos MV; Fernández C; del Mar Babín M; María Navas J; Carbonell G; Martini F; García-Hortigüela P; Vicente Tarazona J
    Ecotoxicol Environ Saf; 2009 Jul; 72(5):1594-600. PubMed ID: 19217160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional in vitro model to examine cancer therapy cytotoxicity in maturing rat testis.
    Nurmio M; Toppari J; Kallio J; Hou M; Söder O; Jahnukainen K
    Reprod Toxicol; 2009 Jan; 27(1):28-34. PubMed ID: 19027063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation.
    Rupertus K; Dahlem C; Menger MD; Schilling MK; Kollmar O
    Ann Surg Oncol; 2009 Sep; 16(9):2629-37. PubMed ID: 19551445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative characterization of bone marrow-derived mesenchymal stromal cells from four different rat strains.
    Barzilay R; Sadan O; Melamed E; Offen D
    Cytotherapy; 2009; 11(4):435-42. PubMed ID: 19521891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reactive nitrogen species switch on early extracellular matrix remodeling via induction of MMP1 and TNFalpha.
    Urtasun R; Cubero FJ; Vera M; Nieto N
    Gastroenterology; 2009 Apr; 136(4):1410-22, e1-4. PubMed ID: 19250650
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a carp primary hepatocyte culture system for screening chemicals for oestrogenic activity.
    Bickley LK; Lange A; Winter MJ; Tyler CR
    Aquat Toxicol; 2009 Sep; 94(3):195-203. PubMed ID: 19695720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Qualitative and quantitative experimental models to aid in risk assessment for immunotoxicology.
    Luster MI; Pait DG; Portier C; Rosenthal GJ; Germolec DR; Comment CE; Munson AE; White K; Pollock P
    Toxicol Lett; 1992 Dec; 64-65 Spec No():71-8. PubMed ID: 1471226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunotoxicity In Vitro Assays for Environmental Pollutants under Paradigm Shift in Toxicity Tests.
    Wang X; Li N; Ma M; Han Y; Rao K
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and utilization of a unique in vitro antigen presentation co-culture model for detection of immunomodulating substances.
    Lehmann DM; Williams WC
    Toxicol In Vitro; 2018 Dec; 53():20-28. PubMed ID: 30048737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proliferation and TH1/TH2 cytokine production in human peripheral blood mononuclear cells after treatment with cypermethrin and mancozeb in vitro.
    Mandarapu R; Ajumeera R; Venkatesan V; Prakhya BM
    J Toxicol; 2014; 2014():308286. PubMed ID: 25328518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro tests to evaluate immunotoxicity: a preliminary study.
    Carfi' M; Gennari A; Malerba I; Corsini E; Pallardy M; Pieters R; Van Loveren H; Vohr HW; Hartung T; Gribaldo L
    Toxicology; 2007 Jan; 229(1-2):11-22. PubMed ID: 17092623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disentangling cellular proliferation and differentiation in the embryonic stem cell test, and its impact on the experimental protocol.
    van Dartel DA; Zeijen NJ; de la Fonteyne LJ; van Schooten FJ; Piersma AH
    Reprod Toxicol; 2009 Sep; 28(2):254-61. PubMed ID: 19442486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound.
    dos Santos GG; Reinders J; Ouwehand K; Rustemeyer T; Scheper RJ; Gibbs S
    Toxicol Appl Pharmacol; 2009 May; 236(3):372-82. PubMed ID: 19232364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional assays are mandatory for a correct prediction of immunotoxic properties of compounds in vitro.
    Koeper LM; Vohr HW
    Food Chem Toxicol; 2009 Jan; 47(1):110-8. PubMed ID: 19022326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of a new cell culture perfusion apparatus for in vitro chronic toxicity testing. Part 2: toxicological evaluation.
    Jennings P; Koppelstaetter C; Pfaller W; Morin JP; Hartung T; Ryan MP
    ALTEX; 2004; 21(2):61-6. PubMed ID: 15195226
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.